Area of research
Surgery · Cancer Research
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, and Urinary and Genital Oncology Studies.
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning
Spatial–Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and the Tumor Immune Microenvironment
HER2 and urothelial carcinoma: current understanding and future directions
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
FGFR Inhibition in Urothelial Carcinoma
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non–organ-confined Upper Tract Urothelial Carcinoma
Immunotherapy in the Treatment of Localized Genitourinary Cancers
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma
The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
Tumor-Infiltrating Myeloid Cells Confer <i>De Novo</i> Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
Sex differences in oncogenic mutational processes
Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature
Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers
Clinical features of neuroendocrine prostate cancer
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer
Sacituzumab Govitecan, a Novel Antibody–Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma